Fractionated stereotactic radiotherapy for uveal melanoma, late clinical results

Radiotherapy and Oncology

Volumn 102, Issue 2, 2012, Pages 219-224

  Muller, Karin ^a   Naus, Nicole ^a   Nowak, Peter J C M ^a   Schmitz, Paul I M ^a   De Pan, Connie ^a   Van Santen, Cornelis A ^a   Marijnissen, Johannes P ^a   Paridaens, Dion A ^b   Levendag, Peter C ^a   Luyten, Gré P M ^c  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ROTTERDAM EYE HOSPITAL   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Fractionated stereotactic radiation therapy; Uveal melanoma

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER GROWTH; CANCER PATIENT; CANCER RADIOTHERAPY; CATARACT; DISEASE SEVERITY; ENUCLEATION; FEMALE; FRACTIONATED STEREOTACTIC RADIOTHERAPY; HUMAN; KERATOCONJUNCTIVITIS SICCA; MAJOR CLINICAL STUDY; MALE; METASTASIS FREE SURVIVAL; NEOVASCULAR GLAUCOMA; NEUROPATHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETINOPATHY; TREATMENT OUTCOME; TUMOR VOLUME; UVEA MELANOMA; VISION; VISUAL ACUITY;

ADULT; AGED; AGED, 80 AND OVER; DOSE FRACTIONATION; EYE ENUCLEATION; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE; STEREOTAXIC TECHNIQUES; SURVIVAL RATE; TREATMENT OUTCOME; UVEAL NEOPLASMS;

EID: 84857629255     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2011.06.038     Document Type: Article

References (56)

1. A.D. Singh, and A. Topham Incidence of uveal melanoma in the United States: 1973-1997 Ophthalmology 110 2003 956 961
2. D.J. Bell, and M.W. Wilson Choroidal melanoma: natural history and management options Cancer Control 11 2004 296 303
3. B. Damato Developments in the management of uveal melanoma Clin Experiment Ophthalmol 32 2004 639 647
4. B. Damato Treatment of primary intraocular melanoma Expert Rev Anticancer Ther 6 2006 493 506
5. J. Fontanesi, D. Meyer, S. Xu, and D. Tai Treatment of choroidal melanoma with I-125 plaque Int J Radiat Oncol Biol Phys 26 1993 619 623
6. M. Georgopoulos, M. Zehetmayer, and I. Ruhswurm Tumour regression of uveal melanoma after ruthenium-106 brachytherapy or stereotactic radiotherapy with gamma knife or linear accelerator Ophthalmologica 217 2003 315 319
7. P.K. Lommatzsch, C. Werschnik, and E. Schuster Long-term follow-up of Ru-106/Rh-106 brachytherapy for posterior uveal melanoma Graefes Arch Clin Exp Ophthalmol 238 2000 129 137
8. S. Nag, J.M. Quivey, J.D. Earle, D. Followill, J. Fontanesi, and P.T. Finger The American Brachytherapy Society recommendations for brachytherapy of uveal melanomas Int J Radiat Oncol Biol Phys 56 2003 544 555
9. S. Packer, S. Stoller, M.L. Lesser, F.S. Mandel, and P.T. Finger Long-term results of iodine 125 irradiation of uveal melanoma Ophthalmology 99 1992 767 773 discussion 774
10. R. Dendale, L. Lumbroso-Le Rouic, and G. Noel Proton beam radiotherapy for uveal melanoma: results of Curie Institut-Orsay proton therapy center (ICPO) Int J Radiat Oncol Biol Phys 65 2006 780 787
11. M. Fuss, L.N. Loredo, P.A. Blacharski, R.I. Grove, and J.D. Slater Proton radiation therapy for medium and large choroidal melanoma: preservation of the eye and its functionality Int J Radiat Oncol Biol Phys 49 2001 1053 1059
12. E.S. Gragoudas, A.M. Lane, J. Munzenrider, K.M. Egan, and W. Li Long-term risk of local failure after proton therapy for choroidal/ciliary body melanoma Trans Am Ophthalmol Soc 100 2002 43 48 discussion 48-49
13. E.S. Gragoudas, J.M. Seddon, and K. Egan Long-term results of proton beam irradiated uveal melanomas Ophthalmology 94 1987 349 353
14. L. Kodjikian, P. Roy, and F. Rouberol Survival after proton-beam irradiation of uveal melanomas Am J Ophthalmol 137 2004 1002 1010
15. G. Modorati, E. Miserocchi, L. Galli, P. Picozzi, and P. Rama Gamma knife radiosurgery for uveal melanoma: 12 years of experience Br J Ophthalmol 93 2009 40 44
16. A.J. Fakiris, S.S. Lo, and M.A. Henderson Gamma-knife-based stereotactic radiosurgery for uveal melanoma Stereotact Funct Neurosurg 85 2007 106 112
17. K. Muller, P.J. Nowak, G.P. Luyten, J.P. Marijnissen, C. de Pan, and P. Levendag A modified relocatable stereotactic frame for irradiation of eye melanoma: design and evaluation of treatment accuracy Int J Radiat Oncol Biol Phys 58 2004 284 291
18. K. Muller, P.J. Nowak, and C. de Pan Effectiveness of fractionated stereotactic radiotherapy for uveal melanoma Int J Radiat Oncol Biol Phys 63 2005 116 122
19. H.M. Kooy, S.F. Dunbar, and N.J. Tarbell Adaptation and verification of the relocatable Gill-Thomas-Cosman frame in stereotactic radiotherapy Int J Radiat Oncol Biol Phys 30 1994 685 691
20. A.P. Warrington, R.W. Laing, and M. Brada Quality assurance in fractionated stereotactic radiotherapy Radiother Oncol 30 1994 239 246
21. J.D. Cox, J. Stetz, and T.F. Pajak Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) Int J Radiat Oncol Biol Phys 31 1995 1341 1346
22. RTOG/EORTC Late Radiation Morbidity Scoring Schema.
23. Cancer Therapy Evaluation Programm, Common Terminology for Adverse Events, Version 3.0, DCTD, NCI, NIH, DHHS March 2003 (http://ctep.cancer.gov). 2003.
24. M. Zehetmayer, K. Dieckmann, and G. Kren Fractionated stereotactic radiotherapy with linear accelerator for uveal melanoma-preliminary Vienna results Strahlenther Onkol 175 1999 74 75
25. K. Dieckmann, M. Zehetmayer, and R. Poetter Fractionated stereotactic radiotherapy for choroidal melanoma Radiother Oncol 49 1998 197
26. J.E. Keunen, J.G. Journee-de Korver, and J.A. Oosterhuis Transpupillary thermotherapy of choroidal melanoma with or without brachytherapy: a dilemma Br J Ophthalmol 83 1999 1212 1213
27. I. Puusaari, B. Damato, and T. Kivela Transscleral local resection versus iodine brachytherapy for uveal melanomas that are large because of tumour height Graefes Arch Clin Exp Ophthalmol 245 2007 522 533
28. K. Tokuuye, Y. Akine, M. Sumi, Y. Kagami, H. Ikeda, and A. Kaneko Fractionated stereotactic radiotherapy for choroidal melanoma Radiother Oncol 43 1997 87 91
29. K. Dieckmann, D. Georg, M. Zehetmayer, J. Bogner, M. Georgopoulos, and R. Potter LINAC based stereotactic radiotherapy of uveal melanoma: 4 years clinical experience Radiother Oncol 67 2003 199 206
30. A.J. Mueller, U. Schaller, S. Talies, G.A. Horstmann, B. Wowra, and A. Kampik Stereotactic radiosurgery using the gamma knife for large uveal melanomas Ophthalmologe 100 2003 122 128
31. H. Krema, S. Somani, and A. Sahgal Stereotactic radiotherapy for treatment of juxtapapillary choroidal melanoma: 3-year follow-up Br J Ophthalmol 93 2009 1172 1176
32. J.R. Castro, D.H. Char, and P.L. Petti 15 years experience with helium ion radiotherapy for uveal melanoma Int J Radiat Oncol Biol Phys 39 1997 989 996
33. P.T. Finger, A. Berson, T. Ng, and A. Szechter Palladium-103 plaque radiotherapy for choroidal melanoma: an 11-year study Int J Radiat Oncol Biol Phys 54 2002 1438 1445
34. L. Bergman, B. Nilsson, G. Lundell, M. Lundell, and S. Seregard Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population Ophthalmology 112 2005 834 840
35. R.M. Conway, A.M. Poothullil, I.K. Daftari, V. Weinberg, J.E. Chung, and J.M. O'Brien Estimates of ocular and visual retention following treatment of extra-large uveal melanomas by proton beam radiotherapy Arch Ophthalmol 124 2006 838 843
36. J. Krohn, O.R. Monge, T.N. Skorpen, S.J. Mork, and O. Dahl Posterior uveal melanoma treated with I-125 brachytherapy or primary enucleation Eye 22 2008 1398 1403
37. D.B. Archer, W.M. Amoaku, and T.A. Gardiner Radiation retinopathy-clinical, histopathological, ultrastructural and experimental correlations Eye 5 1991 239 251
38. K. Gunduz, C.L. Shields, J.A. Shields, J. Cater, J.E. Freire, and L.W. Brady Radiation retinopathy following plaque radiotherapy for posterior uveal melanoma Arch Ophthalmol 117 1999 609 614
39. I. Puusaari, J. Heikkonen, and T. Kivela Effect of radiation dose on ocular complications after iodine brachytherapy for large uveal melanoma: empirical data and simulation of collimating plaques Invest Ophthalmol Vis Sci 45 2004 3425 3434
40. I. Puusaari, J. Heikkonen, and T. Kivela Ocular complications after iodine brachytherapy for large uveal melanomas Ophthalmology 111 2004 1768 1777
41. A. Takeda, N. Shigematsu, and S. Suzuki Late retinal complications of radiation therapy for nasal and paranasal malignancies: relationship between irradiated-dose area and severity Int J Radiat Oncol Biol Phys 44 1999 599 605
42. M.K. Kim, D.H. Char, J.L. Castro, W.M. Saunders, G.T. Chen, and R.D. Stone Neovascular glaucoma after helium ion irradiation for uveal melanoma Ophthalmology 93 1986 189 193
43. P. Summanen, I. Immonen, T. Kivela, P. Tommila, J. Heikkonen, and A. Tarkkanen Radiation related complications after ruthenium plaque radiotherapy of uveal melanoma Br J Ophthalmol 80 1996 732 739
44. E. Egger, A. Schalenbourg, and L. Zografos Maximizing local tumor control and survival after proton beam radiotherapy of uveal melanoma Int J Radiat Oncol Biol Phys 51 2001 138 147
45. J.W. Harbour, D.H. Char, S. Kroll, J.M. Quivey, and J. Castro Metastatic risk for distinct patterns of postirradiation local recurrence of posterior uveal melanoma Ophthalmology 104 1997 1785 1792 discussion 1792-1783
46. J.Y. Niederkorn Enucleation in consort with immunologic impairment promotes metastasis of intraocular melanomas in mice Invest Ophthalmol Vis Sci 25 1984 1080 1086
47. I. Puusaari, J. Heikkonen, P. Summanen, A. Tarkkanen, and T. Kivela Iodine brachytherapy as an alternative to enucleation for large uveal melanomas Ophthalmology 110 2003 2223 2234
48. T.R. Vrabec, J.J. Augsburger, J.W. Gamel, L.W. Brady, C. Hernandez, and R. Woodleigh Impact of local tumor relapse on patient survival after cobalt 60 plaque radiotherapy Ophthalmology 98 1991 984 988
49. C.O.M.S. The Randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. twelve-year mortality rates and prognostic factors: COMS report No. 28 Arch Ophthalmol 124 2006 1684 1693
50. A.Y. Bedikian, S.S. Legha, and G. Mavligit Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors Cancer 76 1995 1665 1670
51. M. Diener-West, J.D. Earle, and S.L. Fine The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS Report No. 18 Arch Ophthalmol 119 2001 969 982
52. S. Eskelin, S. Pyrhonen, M. Hahka-Kemppinen, S. Tuomaala, and T. Kivela A prognostic model and staging for metastatic uveal melanoma Cancer 97 2003 465 475
53. R. Kath, J. Hayungs, N. Bornfeld, W. Sauerwein, K. Hoffken, and S. Seeber Prognosis and treatment of disseminated uveal melanoma Cancer 72 1993 2219 2223
54. L. Kodjikian, J.D. Grange, S. Baldo, S. Baillif, J.G. Garweg, and M. Rivoire Prognostic factors of liver metastases from uveal melanoma Graefes Arch Clin Exp Ophthalmol 243 2005 985 993
55. S. Rajpal, R. Moore, and C.P. Karakousis Survival in metastatic ocular melanoma Cancer 52 1983 334 336
56. P. Rietschel, K.S. Panageas, C. Hanlon, A. Patel, D.H. Abramson, and P.B. Chapman Variates of survival in metastatic uveal melanoma J Clin Oncol 23 2005 8076 8080